Policy & Medicine May 31, 2024
Recently, the United States Department of Health and Human Services (HHS) issued a white paper, “Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States.” The white paper discusses the impact drug shortages have on patients, caregivers, pharmacies, hospitals, nursing homes, and other entities across the health system.
HHS states that drug shortages are often caused by a lack of transparency, concentration among middlemen, and prices for generic drugs that are so low that they create insufficient incentives for resilience-oriented manufacturing, distribution, and purchasing. To help solve the problem of drug shortages, HHS has established a new Supply Chain Resilience and Shortage Coordinator role to strengthen the agency’s coordination and implementation of strategies to enhance...
Today's Sponsors
Today's Sponsor